Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Daley

Showing results (201-210 of 230) with videos related to

Pageof 23
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2020
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice GuidelineCharles L Daley, Jonathan M Iaccarino, Christoph Lange, et al.
American Journal of Respiratory and Critical Care Medicine|February 18, 2003
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosisHenry M Blumberg, William J Burman, Richard E Chaisson, et al.
Infection Control and Hospital Epidemiology|May 9, 2013
A summary of meeting proceedings on addressing variability around the cut point in serial interferon-γ release assay testingCharles L Daley, Randall R Reves, Melodie A Beard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2020
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice GuidelineCharles L Daley, Jonathan M Iaccarino, Christoph Lange, et al.
Journal of Clinical Microbiology|November 20, 2015
Blood Transcriptional Biomarkers for Active Tuberculosis among Patients in the United States: a Case-Control Study with Systematic Cross-Classifier EvaluationNicholas D Walter, Mikaela A Miller, Joshua Vasquez, et al.
The European Respiratory Journal|July 9, 2020
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guidelineCharles L Daley, Jonathan M Iaccarino, Christoph Lange, et al.
The Journal of Infectious Diseases|March 13, 2015
Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human TuberculosisNicholas D Walter, Gregory M Dolganov, Benjamin J Garcia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung DiseaseWon-Jung Koh, Byeong-Ho Jeong, Su-Young Kim, et al.
The European Respiratory Journal|July 13, 2019
Same meat, different gravy: ignore the new names of mycobacteriaEnrico Tortoli, Barbara A Brown-Elliott, James D Chalmers, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 12, 2019
The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research RegistryEdward Eden, Radmila Choate, Alan Barker, et al.
Pageof 23

Showing results (201-210 of 230) with videos related to

Sort By:
Pageof 23
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2020
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice GuidelineCharles L Daley, Jonathan M Iaccarino, Christoph Lange, et al.
American Journal of Respiratory and Critical Care Medicine|February 18, 2003
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosisHenry M Blumberg, William J Burman, Richard E Chaisson, et al.
Infection Control and Hospital Epidemiology|May 9, 2013
A summary of meeting proceedings on addressing variability around the cut point in serial interferon-γ release assay testingCharles L Daley, Randall R Reves, Melodie A Beard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2020
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice GuidelineCharles L Daley, Jonathan M Iaccarino, Christoph Lange, et al.
Journal of Clinical Microbiology|November 20, 2015
Blood Transcriptional Biomarkers for Active Tuberculosis among Patients in the United States: a Case-Control Study with Systematic Cross-Classifier EvaluationNicholas D Walter, Mikaela A Miller, Joshua Vasquez, et al.
The European Respiratory Journal|July 9, 2020
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guidelineCharles L Daley, Jonathan M Iaccarino, Christoph Lange, et al.
The Journal of Infectious Diseases|March 13, 2015
Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human TuberculosisNicholas D Walter, Gregory M Dolganov, Benjamin J Garcia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung DiseaseWon-Jung Koh, Byeong-Ho Jeong, Su-Young Kim, et al.
The European Respiratory Journal|July 13, 2019
Same meat, different gravy: ignore the new names of mycobacteriaEnrico Tortoli, Barbara A Brown-Elliott, James D Chalmers, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 12, 2019
The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research RegistryEdward Eden, Radmila Choate, Alan Barker, et al.
Pageof 23